ClinicalTrials.Veeva

Menu

Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010

G

Gruppo Italiano Malattie EMatologiche dell'Adulto

Status

Not yet enrolling

Conditions

Primary Immune Thrombocytopenia

Study type

Observational

Funder types

Other

Identifiers

NCT06466824
ITP1324

Details and patient eligibility

About

Retrospective data collection on ITP patients who underwent splenectomy from 01/01/2010 to 12/31/2022. The expected enrollment period is 6 months. The observation period of the enrolled patients is at least 1 year.

Full description

Observational, longitudinal, retrospective study on ITP patients. Patients with ITP who underwent splenectomy from 01/01/2010 to 12/31/2022 will be enrolled. All useful data will be collected exclusively through consultation of outpatient medical records. The expected enrollment period is 6 months. The observation period of the enrolled patients is at least 1 year.

Enrollment

157 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged ≥ 18 years
  • Patients with primary ITP according to international criteria [2], who underwent to splenectomy from 01/01/2010 to 12/31/2022.
  • Obtaining Informed Consent.

Exclusion criteria

  • none

Trial contacts and locations

0

Loading...

Central trial contact

Enrico Crea; Paola Fazi

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems